Table 3 Contraception related information of respondents at Addis Ababa government hospitals, Addis Ababa, Ethiopia, 2022 (n = 389)
Variables | Frequency (N) | Percentage (%) |
|---|---|---|
Type of LARC discontinued | ||
Implanon | 275 | 70.7 |
IUCD | 77 | 19.8 |
Jadelle | 37 | 9.5 |
LARC discontinuation | ||
Early discontinuation (< 24 months) | 236 | 60.7 |
Late discontinuation (> 24 months) | 153 | 39.3 |
Mean ± SD, (range in months) | 22.9 ± 13 (3–85) | |
Facility of insertion | ||
Government hospital | 295 | 75.8 |
Health centers | 64 | 16.5 |
Others a | 30 | 7.7 |
Institution of insertion | ||
SPHMMC | 203 | 52.2 |
Other facilities | 186 | 47.8 |
Presence of side effects | ||
Yes | 256 | 65.8 |
No | 133 | 34.2 |
Counseling on benefit of LARC | ||
Yes | 368 | 94.6 |
No | 21 | 5.4 |
Counseling on side effects of LARC | ||
Yes | 253 | 65.7 |
No | 132 | 34.3 |
Reason for LARC removal | ||
Due to side effects | 154 | 39.6 |
Need of pregnancy | 173 | 44.5 |
Others b | 62 | 15.9 |
Side effects that resulted Removal (n = 160) | ||
Menstrual abnormality | 94 | 58.7 |
Pain | 24 | 15 |
Weight gain | 20 | 12.5 |
Others | 22 | 13.7 |
Choice of LARC | ||
Her own choice | 227 | 58.4 |
Influence from others d | 162 | 41.6 |